News
Acceleron Pharma discontinues development of muscular dystrophy drug
The clinical-stage biopharmaceutical company Acceleron Pharma Inc. has announced the discontinuation of the development of drug for facioscapulohumeral muscular dystrophy (FSHD), ACE-083. Further clinical trials...
News
Sharp appoints Sascha Sonnenberg as Global Head of Business...
Sharp, part of UDG Healthcare and a leading provider of clinical supply services, has strengthened its leadership team with the appointment of Sascha Sonnenberg as...
News
USV to invest Rs 4000 million in a new...
Following the Indian Government’s surprise move to cut corporate tax rates, USV Pvt.Ltd., an Indian multinational Pharma and Biotech company has announced that it will...
News
PPD Expanding Bioanalytical Laboratory Capabilities
Pharmaceutical Product Development, LLC (PPD), is expanding its bioanalytical laboratory in Richmond, Virginia, enhancing its ability to provide industry-leading capabilities to meet biopharmaceutical clients’ increasing...
News
PCI unveils expanded clinical services center in Rockford
PCI Pharma services We have officially opened our new expansion to our Clinical Center of Excellence in Rockford, IL.
Rockford City Council Director of Community and...
Clinical Trials
Academic Medical Center System Infrastructure Trends and Related Challenges...
Though academic medical centers (AMCs) may differ widely—public vs private, city vs rural, and system infrastructure and resource variations—they generally share the same tripartite mission:...
News
Centrexion eyes the IPO to fund its phase 3...
In its attempt to list on the NASDAQ, Centrexion Therapeutics has restarted the effort of going public yet again. The biotech company through the IPO...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.